These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 15222656)
1. Tiotropium (Spiriva) for COPD. Hutton SF Am Fam Physician; 2004 Jun; 69(12):2901-2. PubMed ID: 15222656 [No Abstract] [Full Text] [Related]
2. Incorporating tiotropium into a respiratory therapist-directed bronchodilator protocol for managing in-patients with COPD exacerbations decreases bronchodilator costs. Drescher GS; Carnathan BJ; Imus S; Colice GL Respir Care; 2008 Dec; 53(12):1678-84. PubMed ID: 19025702 [TBL] [Abstract][Full Text] [Related]
3. [Tiotropium bromide (Spiriva) in stablechronic obstructive pulmonary disease]. Lobzhanidze TV; Sikharulidze LP; Kurdegeliia MR Georgian Med News; 2007; (148-149):29-31. PubMed ID: 17921539 [TBL] [Abstract][Full Text] [Related]
4. Tiotropium: a bronchodilator for chronic obstructive pulmonary disease. Somand H; Remington TL Ann Pharmacother; 2005 Sep; 39(9):1467-75. PubMed ID: 16030078 [TBL] [Abstract][Full Text] [Related]
5. Tiotropium (Spiriva) for COPD. Med Lett Drugs Ther; 2004 May; 46(1183):41-2. PubMed ID: 15159658 [No Abstract] [Full Text] [Related]
6. [The efficacy of tiotropium bromide (spiriva) in the treatment of patients with chronic obstructive pulmonary disease of varying severity: results of the Russian trial]. Stepanian IE; Khmel'kova NG; Belin-Atarac B Ter Arkh; 2010; 82(10):46-51. PubMed ID: 21341464 [TBL] [Abstract][Full Text] [Related]
7. [Tiotropium: a new therapeutic option in chronic obstructive pulmonary disease]. Corhay JL; Louis R Rev Med Suisse; 2005 Aug; 1(30):1967-9, 1971-2. PubMed ID: 16200941 [TBL] [Abstract][Full Text] [Related]
8. Evaluating the pharmacoeconomic effect of adding tiotropium bromide to the management of chronic obstructive pulmonary disease patients in Singapore. Lee KH; Phua J; Lim TK Respir Med; 2006 Dec; 100(12):2190-6. PubMed ID: 16635566 [TBL] [Abstract][Full Text] [Related]
9. [2005 Robert Koch Award for tiotropium. Quality leap in therapy of COPD]. MMW Fortschr Med; 2005 May; 147(19):55. PubMed ID: 15940942 [No Abstract] [Full Text] [Related]
10. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities]. Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N; Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228 [TBL] [Abstract][Full Text] [Related]
11. Tiotropium in chronic obstructive pulmonary disease. Chang ET N Engl J Med; 2009 Jan; 360(2):185; author reply 187. PubMed ID: 19137623 [No Abstract] [Full Text] [Related]
12. Tiotropium in chronic obstructive pulmonary disease. O'Connor AB N Engl J Med; 2009 Jan; 360(2):185-6; author reply 187. PubMed ID: 19137624 [No Abstract] [Full Text] [Related]
13. Tiotropium in chronic obstructive pulmonary disease. Sierra-Sánchez JF; Alegre-del Rey EJ; Cobo I N Engl J Med; 2009 Jan; 360(2):186-7; author reply 187. PubMed ID: 19137625 [No Abstract] [Full Text] [Related]
14. The role of tiotropium in the hospital management of exacerbation of chronic obstructive pulmonary disease. Tashkin DP Respir Care; 2008 Dec; 53(12):1657-9. PubMed ID: 19025697 [No Abstract] [Full Text] [Related]
16. Economic evaluation of tiotropium and salmeterol in the treatment of chronic obstructive pulmonary disease (COPD) in Greece. Maniadakis N; Tzanakis N; Fragoulakis V; Hatzikou M; Siafakas N Curr Med Res Opin; 2006 Aug; 22(8):1599-607. PubMed ID: 16870084 [TBL] [Abstract][Full Text] [Related]
17. [Can tiotropium bromide favorably influence the course of disease?]. Stiefelhagen P Med Monatsschr Pharm; 2006 Aug; 29(8):308-9. PubMed ID: 16927602 [No Abstract] [Full Text] [Related]
18. [Experience of practical use of sustained-release M-cholinolytic agent thiotropium bromide (Spiriva) in patients with chronic obstructive lung disease]. Shmelev EI; Khmel'kova MA Probl Tuberk Bolezn Legk; 2006; (5):53-5. PubMed ID: 16850926 [No Abstract] [Full Text] [Related]
19. [Tiotropium, a long-acting bronchodilating agent for the treatment of COPD]. Schuurbiers OC; Schermer TR; Dekhuijzen PN; van Weel C Ned Tijdschr Geneeskd; 2006 Jun; 150(22):1227-32. PubMed ID: 16796173 [TBL] [Abstract][Full Text] [Related]